The report publishes a ranking of the 16 most important Spanish institutions in terms of economic return. In this ranking, IDIBAPS stands out in fourth position with 3 projects funded and FCRB in the ninth position with 4 of them. The good results at the institutional level are also reflected in our researchers’ participation in approved projects in the 2014-2015 H2020 program:
|
Call |
Project |
Principal Investigator |
Institution |
|
Societal challenge 1: Personalising Health and Care |
|||
|
2014 |
Cost effective self-management of urinary incontinence addressed to women (WOMEN-UP) |
Dra. Montse Espuña |
FCRB |
|
2015 |
Development of a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes (T2DSystems) |
Dr. Jorge Ferrer |
IDIBAPS |
|
2015 |
A EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates (EHVA) |
Dr. Jose Maria Gatell |
IDIBAPS |
|
2014 |
Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease (CARBALIVE) |
Dr. Pere Ginès |
IDIBAPS |
|
2015 |
European AIDS Vaccine Initiative 2020 (EAVI2020) |
Dr. Joan Joseph |
FCRB |
|
2014 |
Evaluating mHealth technology in HIV to improve Empowerment and healthcare utilisation (EmERGE) |
Dra. Agata León |
FCRB |
|
2015 |
Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities (HEP-CAR) |
Dr. Josep Maria Llovet |
IDIBAPS |
|
2014 |
Characterizing Atrial fibrillation by Translating its Causes into Health Modifiers in the Elderly (CATCH ME) |
Dr. Lluís Mont |
IDIBAPS |
|
2014 |
Sustainable intEgrated care modeLs for multi-morbidity: delivery, FInancing and performance (SELFIE) |
Dr. Josep Roca |
IDIBAPS |
|
2014 |
Aortic Valve Replacement using Individualised Regenerative Allografts: Bridging the Therapeutic Gap (ARISE) |
Dra. Marta Sitges |
IDIBAPS |
|
2014 |
Conservative iron chelation as a disease-modifying strategy in Parkinsons disease: a multicentric parallel-group,placebo-controlled, randomized clinical trial of deferiprone (FAIR-PARK-II) |
Dr. Eduardo Tolosa |
FCRB |
|
Excellent Science: Marie Sklodowska- Curie actions |
|||
|
Innovative Training Networks 2014 |
Computational and functional annotation of genomic elements during development of the model vertebrate zebrafish (ZENCODE) |
Dr. Jorge Ferrer |
IDIBAPS |
|
Individual Fellowships 2014 |
Analysis of tridimensional changes caused by type 2 Diabetes-Associated varianTs (3D-ADAPT) |
Dra. Irene Miguel-Escalada |
IDIBAPS |
|
Innovative Training Networks 2015 |
Regulation of red cell life-span, erythropoiesis, survival, senescence and clearance (RELEVANCE) |
Dr. Joan Lluís VivesCorrons |
IDIBAPS |
|
Industrial Leadership: Leadership in Enabling and Industrial Technologies |
|||
|
ICT- 2015 |
Laser and Ultrasound Co-Analyzer for thyroid nodules (LUCA) |
Dr. Ramon Gomis |
IDIBAPS |
|
ICT- 2014 |
A Framework for user centred privacy and security in the cloud (CLARUS) |
Dr. David Vidal |
FCRB |
|
3rd Health Programme (CHAFEA) |
|||
|
2014 |
Stimulating Innovation Management of Polypharmacy and Adherence in The Elderly (SIMPATHY) |
Dr. Carles Codina |
FCRB |
|
ERA-NETS |
|||
|
EraCoSysMed2015 |
Personalizing health care in Multiple Sclerosis using systems medicine tolos (Sys4MS) |
Dr. Pablo Villoslada (Coordinator) |
IDIBAPS |
|
eRARE2015 |
A comprehensive clinical and experimental approach to personalized molecular medicine in patients with defined and undefined autoinflammatory disorders (INSAID) |
Dr. Juan Aróstegui |
FCRB |
|
TransCan2015 |
Genetic and cellular intratumor heterogeneity as predictor of chronic lymphocytic leukemiaoutco resistance (GCH-CLL) |
Dr. Elias Campo |
FCRB |
|
InfectEra2015 |
SRCR proteins as microorganism pattern recognition receptors: a wide search for interactions with pathogenic bacteria (SRecognite) |
Dr. Francisco Lozano |
IDIBAPS |
|
NEURON 2014 |
Advancing an antigen-specific nanomedicine for the treatment of central nervous system autoimmunity (MS NANOMED) |
Dr. Pau Serra |
FCRB |
|
FET Flagships |
|||
|
Human Brain Project |
Slow Wave Dynamics: from experiments, analysis and models to rhythm restoration (SloW-Dyn) |
Dra. Maria Victoria Sánchez (Coordinator) |
IDIBAPS |
|
Human Brain Project |
WAVE SCALing Experiments and Simulations (WaveScalIES) |
Dra. Maria Victoria Sánchez |
IDIBAPS |
|
Graphene |
Graphene-based disruptive technologies (Graphenecore 1) |
Dra. Maria Victoria Sánchez |
IDIBAPS |
Spanish institutions and companies are involved in 61 of the 114 activities that have received funding in the field of health; they lead 17 activities, of which 15 are Research and Innovation Action y Innovation Action proposals.
Notably, public research centers are in second place in terms of uptake of these resources and Catalonia is the region that leads the Spanish ranking.
The analysis is based on the first open calls within the new framework program. For more information, consult the CDTI report:
Spanish Participation in Horizon 2020: European Comission's framework program (2014-2020)